Predictive factors of non-deterioration of glucose tolerance following a 2-year behavioral intervention

Diabetology and Metabolic Syndrome

Volumn 2, Issue 1, 2010, Pages

  Almeida Pititto, Bianca ^a   Hirai, Amélia T ^b   Sartorelli, Daniela S ^a   Harima, Helena A ^b   Gimeno, Suely Ga ^b   Ferreira, Sandra Rg ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ANTHROPOMETRY; ARTICLE; BEHAVIOR THERAPY; BODY WEIGHT; BRAZIL; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; JAPANESE; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL ACTIVITY; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 77955543090     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-2-52     Document Type: Article

References (25)

1. Standard definitions of overweight and central adiposity for determining diabetes risk in Japanese Americans. MJ McNeely EJ Boyko JB Shofer L Newell-Morris DL Leonetti WY Fujimoto, Am J Clin Nutr 2001 74 101 107 11451724
2. Elevated C-reactive protein is a risk factor for the development of type 2 diabetes in Japanese Americans. S Nakanishi K Yamane N Kamei M Okubo N Kohno, Diabetes Care 2003 26 2754 2757 10.2337/diacare.26.10.2754 14514575
3. Prevalence and 7-year incidence of type 2 diabetes mellitus in a Japanese-Brazilian population: an alarming public health problem. SGA Gimeno SRG Ferreira LJ Franco A Hirai L Matsumura RCS Moisés for the Japanese-Brazilians Diabetes Study Group, Diabetologia 2002 45 1635 1638 10.1007/s00125-002-0963-x 12488952
4. Analysis of criteria for metabolic syndrome in a population-based study of Japanese-Brazilians. P Rosenbaum SGA Gimeno A Sanudo LJ Franco SRG Ferreira, Diabetes Obes Metab 2005 7 4 352 359 10.1111/j.1463-1326.2004.00402.x 15955121
5. Dietary intakes associated with metabolic syndrome in a cohort of Japanese ancestry. RD Freire TG Castro MA Cardoso SGA Gimeno SRG Ferreira, Br J Nutr 2006 96 3 532 538 16925859
6. Prevention of Type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. J Tuomilehto J Lindstrom JG Eriksson TT Valle H Hamalainen P Ilanne-Parikka S Keinanen-Kiukaanniemi M Laakso A Louheranta M Rastas V Salminen M Uusitupa for the FINNISH Diabetes Prevention Study Group, N Engl J Med 2001 344 18 1343 1350 10.1056/NEJM200105033441801 11333990 (Pubitemid 32378388)
7. The Diabetes Prevention Program: reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. WC Knowler E Barrett-Connor SE Fowler RF Hamman JM Lachin EA Walker DM Nathan, N Engl J Med 2002 346 393 403 10.1056/NEJMoa012512 11832527
8. Researching how to realise the potential of diabetes prevention. RK Simmons SJ Griffin NJ Wareham, Diabet Med 2007 24 10 1055 1057 10.1111/j.1464-5491.2007.02260.x 17888126
9. Determinants for the effectiveness of lifestyle intervention in the Finnish Diabetes prevention Study. J Lindstrom M Peltonen JG Eriksson S Aunola H Hamalainen P Ilanne-Parikka Keinanen-Kiukaanniemi M Uusitpa J Tuomilehto for the Finnish Diabetes Prevention Study (DPS) Group, Diabetes Care 2008 31 857 862 10.2337/dc07-2162 18252900
10. ietary n-3 fatty acid and n-3:n-6 fatty acids ratio predict improvement in glucose disturbances in Japanese-Brazilians. DS Sartorelli R Damio R Chaim A Hirai SG Gimeno SRG Ferreira Japanse-Brazilian Diabetes Study Group JBDSG, Nutrition 2010 26 184 191 10.1016/j.nut.2009.03.013 19647413
11. Source: IPEADATA. http://www.ipeadata.gov.br
12. World Health Organization & Food and Agricultural Organization: The scientific basis for diet, nutrition and the prevention of type 2 diabetes. Geneva 2003
13. Primary prevention of type 2 diabetes through nutritional counseling. DS Sartorelli EC Sciarra LJ Franco MA Cardoso, Diabetes Care 2004 27 3019 10.2337/diacare.27.12.3019 15562232
14. Obesity: preventing and managing the global epidemic. Report of WHO Consultation on Obesity. World Health Organization, Geneva 1998
15. Steering Committee of the Western Pacific Region of the WHO, the International Association for the Study of Obesity Task Force. The Asia-Pacific perspective: redefining obesity and its treatment. World Health Organization-WHO, 2000
16. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. The JNC 7 Report. JAMA 2003 289 19 2560 72 10.1001/jama.289.19.2560 12748199
17. Position Statement. Screening for Type 2 Diabetes. American Diabetes Association, Diabetes Care 2003 26 21 S24 10.2337/diacare.26.2007.S21 12502615
18. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP), JAMA 2001 285 2486 97 10.1001/jama.285.19.2486 11368702
19. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. DR Matthews JP Hosker AS Rudenski BA Naylor DF Treacher RC Turner, Diabetologia 1985 28 412 9 10.1007/BF00280883 3899825
20. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. TS Han N Sattar K Williams C Gonzalez-Villalpando ME Lean SM Haffner, Diabetes Care 2002 25 2016 2021 10.2337/diacare.25.11.2016 12401749
21. C-reactive protein is an independent predictor of risk for the development of diabetes in the West Scotland Coronary Prevention Study. DJ Freeman J Norrie MJ Caslake A Gaw I Ford GD Lowe DS O'Reilly CJ Packard N Sattar, Diabetes 2002 51 1596 1600 10.2337/diabetes.51.5.1596 11978661
22. C-reactive protein as a predictor for incident diabetes mellitus among middle aged men: results from the MONICA Augsburg Cohort Study, 1984-1998. B Thorand H Lowel A Schneider H Kolb C Meisinger M Frohlich W Koenig, Arch Intern Med 2003 163 93 99 10.1001/archinte.163.1.93 12523922
23. Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF- or its receptors. S Muller S Martin W Koenig P Hanifi-Moghaddam W Rathmann B Haastert G Giani T Illig B Thorand H Kolb, Diabetologia 2002 45 805 812 10.1007/s00125-002-0829-2 12107724
24. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). A Ramachandran C Snehalatha S Mary B Mukesh AD Bhaskar V Vijay Indian Diabetes Prevention Programme (IDPP), Diabetologia 2006 49 2 289 297 10.1007/s00125-005-0097-z 16391903
25. Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. K Kosaka M Noda T Kuzuya, Diabetes Res Clin Pract 2005 67 2 152 62 10.1016/j.diabres.2004.06.010 15649575